John M. Evans

CEO

John M. Evans (CEO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales, 1 filed past the two-business-day deadline), most often in Beam Therapeutics Inc. (BEAM). The largest single filing was $1.7M of BEAM (48,100 sh across 3 lots, as filed), executed Jun 29.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells · 1 late

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$6.1M

shares × price, as filed

Last traded

Jun 30

Filed Jul 1

Median ADV $56.9M across their filed names

Open performance→

Volume by month

Buys $0 Sells $9.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

BEAM

Beam Therapeutics Inc. BEAM · 0 buys · 8 sells 8 filings

Recent filings

BEAMSALE Beam Therapeutics Inc. View filing → $1.7M
48,100 sh across 3 lots
Exec Jun 29
Filed Jul 1 · 4:05 PM ET BEAMSALE Beam Therapeutics Inc. View filing → $739K
30,078 sh × $24.58
Exec Apr 1
Filed Apr 6 · 5:30 PM ET † BEAMSALE Beam Therapeutics Inc. View filing → $1.1M
50,000 sh across 2 lots
Exec Mar 30
Filed Apr 1 · 5:30 PM ET BEAMSALE Beam Therapeutics Inc. View filing → $1.4M
47,094 sh across 3 lots
Exec Jan 29
Filed Feb 2 · 5:30 PM ET BEAMSALE Beam Therapeutics Inc. View filing → $1.2M
50,000 sh across 2 lots
Exec Oct 1 2025
Filed Oct 3 2025 · 5:30 PM ET BEAMSALE Beam Therapeutics Inc. View filing → $563K
30,663 sh × $18.35
Exec Apr 1 2025
Filed Apr 3 2025 · 5:30 PM ET BEAMSALE Beam Therapeutics Inc. View filing → $797K
29,800 sh × $26.75
Exec Jan 30 2025
Filed Feb 3 2025 · 5:30 PM ET BEAMSALE Beam Therapeutics Inc. View filing → $1.5M
60,000 sh × $24.60
Exec Sep 30 2024
Filed Oct 2 2024 · 5:30 PM ET